Urticaria News and Research

RSS
Urticaria are itchy, raised red areas on the skin. Urticaria are caused by a reaction to certain foods, drugs, infections, or emotional stress. Also called hives.
Dyax initiates ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

Dyax initiates ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

ORENCIA SC formulation receives FDA approval for treatment of adults with RA

ORENCIA SC formulation receives FDA approval for treatment of adults with RA

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

FDA approves Merz Aesthetics' XEOMIN for temporary improvement of glabellar lines

FDA approves Merz Aesthetics' XEOMIN for temporary improvement of glabellar lines

AMAG enters definitive merger agreement with Allos Therapeutics

AMAG enters definitive merger agreement with Allos Therapeutics

PENNSAID Viscous Solution Phase 2 clinical trial for osteoarthritis pain meets primary endpoint

PENNSAID Viscous Solution Phase 2 clinical trial for osteoarthritis pain meets primary endpoint

EMA CHMP issues positive opinion for Baxter's IVIG therapy for multifocal motor neuropathy

EMA CHMP issues positive opinion for Baxter's IVIG therapy for multifocal motor neuropathy

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Daiichi Sankyo, Regency Therapeutics launch SPRIX Nasal Spray for severe pain

Daiichi Sankyo, Regency Therapeutics launch SPRIX Nasal Spray for severe pain

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Study explores link between alexithymia and auto-immune disease

Study explores link between alexithymia and auto-immune disease

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Baxter's ARTISS phase III study results in face lift surgery presented at AAPS meeting

Baxter's ARTISS phase III study results in face lift surgery presented at AAPS meeting

Merck enters definitive agreement to acquire Inspire

Merck enters definitive agreement to acquire Inspire

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Grifols receives FDA approval for Alphanate to treat vCJD

Grifols receives FDA approval for Alphanate to treat vCJD